Per 25 mcg/125 mcg inhaler Salmeterol xinafoate 25 mcg, fluticasone propionate 125 mcg. Per 25 mcg/250 mcg inhaler Salmeterol xinafoate 25 mcg, fluticasone propionate 250 mcg
Regular treatment of asthma in patients not adequately controlled w/ inhaled corticosteroids & 'as needed' inhaled short-acting β2-agonist; in patients already adequately controlled on both inhaled corticosteroids & long-acting β2-agonist.
Should not be used to treat acute asthma. Avoid abrupt discontinuation. Patients w/ pulmonary TB, severe CV disorders, heart rhythm abnormalities, DM, thyrotoxicosis, uncorrected hypokalemia & predisposed to low levels of serum K. Pregnancy & lactation.
R03AK06 - salmeterol and fluticasone ; Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.